BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23751876)

  • 1. Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.
    Sponziello M; Lavarone E; Pegolo E; Di Loreto C; Puppin C; Russo MA; Bruno R; Filetti S; Durante C; Russo D; Di Cristofano A; Damante G
    Endocrinology; 2013 Sep; 154(9):3043-53. PubMed ID: 23751876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.
    Pringle DR; Vasko VV; Yu L; Manchanda PK; Lee AA; Zhang X; Kirschner JM; Parlow AF; Saji M; Jarjoura D; Ringel MD; La Perle KM; Kirschner LS
    J Clin Endocrinol Metab; 2014 May; 99(5):E804-12. PubMed ID: 24512487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
    Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
    Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-G is differentially expressed in thyroid tissues.
    de Figueiredo Feitosa NL; Crispim JC; Zanetti BR; Magalhães PK; Soares CP; Soares EG; Neder L; Donadi EA; Maciel LM
    Thyroid; 2014 Mar; 24(3):585-92. PubMed ID: 24089994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
    Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
    Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type.
    Inaba M; Umemura S; Satoh H; Abe Y; Kurokawa K; Sakai H; Osamura RY
    Pathol Int; 2003 Mar; 53(3):146-53. PubMed ID: 12608895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland.
    Czyz W; Balcerczak E; Rudowicz M; Niewiadomska H; Pasieka Z; Kuzdak K; Mirowski M
    Folia Histochem Cytobiol; 2003; 41(2):91-5. PubMed ID: 12722795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
    Zhang H; Zhang Z; Liu X; Duan H; Xiang T; He Q; Su Z; Wu H; Liang Z
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1011-1021. PubMed ID: 33394038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.
    Colamaio M; Puca F; Ragozzino E; Gemei M; Decaussin-Petrucci M; Aiello C; Bastos AU; Federico A; Chiappetta G; Del Vecchio L; Torregrossa L; Battista S; Fusco A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E59-69. PubMed ID: 25238203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
    Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors.
    Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F
    J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.
    Camacho CP; Latini FR; Oler G; Hojaij FC; Maciel RM; Riggins GJ; Cerutti JM
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):475-83. PubMed ID: 18727708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis.
    Keelawat S; Thorner PS; Shuangshoti S; Bychkov A; Kitkumthorn N; Rattanatanyong P; Boonyayothin W; Poumsuk U; Ruangvejvorachai P; Mutirangura A
    J Endocrinol Invest; 2015 Jul; 38(7):725-32. PubMed ID: 25740063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
    Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
    Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
    Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
    Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.
    Colamaio M; Borbone E; Russo L; Bianco M; Federico A; Califano D; Chiappetta G; Pallante P; Troncone G; Battista S; Fusco A
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1915-24. PubMed ID: 21956418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling demonstrates differential expression of osteopontin in follicular thyroid carcinomas compared to normal thyroid tissue in dogs.
    Metivier KS; Deitz K; Xu WW; Conzemius M; Wilke VL
    Vet Comp Oncol; 2014 Sep; 12(3):181-97. PubMed ID: 22925004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.